FiercePharma21 小时
Incyte's JAK cream Opzelura picks up steam as company works to revive Jakafi XR dreams
Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...
Scandal of the women harmed by medical implants who are BANNED from seeking compensation
Emma-Louise Lucas, a mother of one from Manchester, at just 31 received the shocking news that she had a rare type of cancer ...